CordenPharma has expanded its peptide manufacturing capacity in CordenPharma Colorado, their GMP API facility in Boulder, Colorado. The expansion was done in order to accommodate for a large spike in demand for peptide API’s and to continue an overall growth strategy.   Dr. Matthieu Giraud, director, Global Peptides, Lipids & Carbohydrates Platform, explained, “With the addition of this extra-large 3’000 L SPPS vessel, our assembly-time, capacity and flexibility has been significantly incr...